Poseida Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
10 Jan 2025	Form 4: Malin Life Sciences Holdings Ltd, 10% owner Disposed of 11,835,673 shares (Tender Offer)
08 Jan 2025	Form 4: Schmid John P., Director Disposed of 58,950 shares (Tender Offer) · Disposed of 197,147 Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Amado Rafael, Director Disposed of 58,950 shares (Tender Offer) · Disposed of 82,550 Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Corning Luke, Director Disposed of 58,950 shares (Tender Offer) · Disposed of 129,033 Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Lloyd Marcea Bland, Director Disposed of 68,950 shares (Tender Offer) · Disposed of 197,147 Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Leonhardt Harry J, GC & Chief Compliance Officer Disposed of 223,640 shares (Tender Offer) · Disposed of 606,936 Employee Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Gergen Mark J, Director Disposed of 636,726 shares (Tender Offer) · Disposed of 1,760,996 Employee Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Yarema Kristin, President and CEO Disposed of 615,836 shares (Tender Offer) · Disposed of 843,525 Employee Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Collins Cynthia, Director Disposed of 58,950 shares (Tender Offer) · Disposed of 170,640 Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Baum Charles M, Director Disposed of 78,600 shares (Tender Offer) · Disposed of 111,700 Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Mylet Johanna, Chief Financial Officer Disposed of 254,852 shares (Tender Offer) · Disposed of 575,860 Employee Stock Option (Right to Buy) (Disposition to Issuer)
08 Jan 2025	Form 4: Rizvi Syed Ali-aamir, Chief Medical Officer Disposed of 185,000 shares (Tender Offer) · Disposed of 250,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Jan 2025	Form 4: Gergen Mark J, Director Gave up 23,313 shares to cover exercise price or tax ($224K)
11 Dec 2024	Form 4: Gergen Mark J, Director Received 30,000 shares by exercise or conversion ($83.4K) · Sold 30,000 shares ($284K)
27 Nov 2024	Form 4: Gergen Mark J, Director Received 30,000 shares by exercise or conversion ($83.4K) · Sold 30,000 shares ($278K)
18 Jun 2024	Form 4: Schmid John P., Director Received 19,650 shares as a grant or award · Granted 27,350 Stock Option (Right to buy)
18 Jun 2024	Form 4: Lloyd Marcea Bland, Director Received 19,650 shares as a grant or award · Granted 27,350 Stock Option (Right to buy)
18 Jun 2024	Form 4: Collins Cynthia, Director Received 19,650 shares as a grant or award · Granted 27,350 Stock Option (Right to buy)
18 Jun 2024	Form 4: Baum Charles M, Director Received 19,650 shares as a grant or award · Granted 27,350 Stock Option (Right to buy)
18 Jun 2024	Form 4: Corning Luke, Director Received 19,650 shares as a grant or award · Granted 27,350 Stock Option (Right to buy)

Comments